Search Results

Your search matched 49 results

  • 1
  • 2
#1

Engaging Media During Unprecedented Times: Insights for Your Business From a National Press Survey | Perspectives

To help Syneos Health public relations agencies and clients navigate the media relations landscape during the pandemic, we conducted a survey in which we asked journalists to share insights on their coverage of health, medical and pharma/biotech industry topics.

#2

2020 Employee Communications and Behavioral Science Contingency | Perspectives

Recommendations for activities to inform and engage

#3

Healthcare More Streamlined, Consumerized Post COVID-19 | Blog

Though once overwhelmed by the pandemic, many healthcare systems have already restructured themselves after learning critical lessons from COVID-19.

#4

Life Sciences Commercialization in the COVID-19 Era: Critical Pivot Points to Mitigate Risk | Perspectives

Learn how to pivot and adapt your commercialization and communications tactics amid COVID-19 with insights from Rich Gorman and Leigh Householder at Syneos Health in this Xtalks webinar.

#5

Why Hospitals Really Like the Changes They Made for COVID-19 | Blog

As the pandemic surged, New York City’s Mt.

#6

Here are a Few Changes We Can Expect to See in Our World After COVID | Blog

COVID-19 has accelerated the rate at which we’re seeing change happening around us.

#7

Leading Through Uncertainty Amidst the Global Pandemic | Perspectives

Communities across the world are facing unprecedented times with a global pandemic affecting over 100+ countries.

#8

COVID-19: Optimizing Promotions with HCP Preferences | Perspectives

Understanding HCP concerns and preferences for personal promotions in the time of COVID-19.

#9

Israel Gets Head Start in Race for COVID-19 Vaccine | Blog

For four years, scientists at MIGAL, the Galilee Research Institute, had been working on a COVID-19 vaccine without knowing it.

#10

Best Practices: Social Media Content and Activity During COVID-19 | Perspectives

In this PM360 article, Steve Marino, Managing Director of Digital & Social Strategy at Syneos Health Communications, shares "guidance (that) can help marketers navigate their way as they make decisions about what types of content to post, and what not to post."

#11

Demonstrating Value in the Real World | Perspectives

Life sciences companies have a variety of tools to demonstrate the value of their medicines in the real world, but any innovative agreement or study should definitively answer these five questions.

#12

Contingency 2020: Four Strategic Ways to Maintain Momentum Through Disruption | Perspectives

Four Rapid Response Approaches To Maintain Business Momentum

#13

Adapt, Don’t Cancel: How to Go Virtual When Attendees Can’t Travel | Perspectives

Virtual delivery requires you to rethink your content and approaches.

#14

P2P Networks Huge for COVID-19 Patients, Responders | Blog

Best practices for avoiding the novel corona virus are fairly well publicized, but for people who have contracted COVID-19 guidance can be harder to come by.

#15

COVID vaccine deemed essential to re-opening activities—But, no-thanks, it’s not for me! | Blog

With the dramatic impact that COVID 19 has had on work, school, social engagements, and overall life as we know it, one would think that people would be anxious to be vaccinated.

#16

Peer To Peer Insights in the COVID-19 Era and Beyond | Perspectives

COVID-19 has introduced an era of unprecedented events to industries across the globe.

#17

The Syneos Health Podcast, Coronavirus Special Edition: COVID-19 and Children | Perspectives

Over the course of the COVID-19 pandemic, information has varied around whether or not – and how severely – children are affected by the virus.

#18

Clear, Consistent Healthcare Communication: Lessons from COVID-19 | Blog

Patients are often at risk when presented with mixed messages.

#19

COVID-19 Kicks Drug Pricing Down the Road | In The Media

Meg Alexander, head of the reputation and risk management practice at Syneos Health, and Jeff Stewart, managing director at Syneos Health Consulting, teamed up with MM&M to discuss implications of COVID-19 and the upcoming US election on drug pricing.

#20

How Health Tech is Helping Countries Around the World Tackle Coronavirus | Blog

With an increasing number of coronavirus cases popping up around the world, countries are taking action by leveraging innovative health tech to protect the safety of the public without compromising the care they need.

#21

MM&M eBook: Marketing in a Crisis | In The Media

In the "Marketing in a Crisis" eBook by MM&M, Scott Page of GSW, a Syneos Health company, says: “We are in this business of healthcare because it is a higher calling."

#22

The Syneos Health Podcast, Coronavirus Special Edition: The Leader's Experience | Perspectives

In this episode of our Coronavirus Special Edition Series, Syneos Health CEO Alistair Macdonald discusses the unique decisions to be made as a pharmaceutical organization practicing corporate responsibility in the name of public health.

#23

First COVID-19 Treatment Approved by FDA | Blog

The Food and Drug Administration (FDA) has approved the use of Veklury (remdesivir) for use in adult and adolescent patients 12 years of age and older for the treatment of COVID-19 in instances that require hospitalization.

#24

PHARMA TRENDS 2020—2025: Four Headwinds Driving Healthcare Transformation — and What We’re Doing | Blog

How COVID-19 and 3 other barriers will transform healthcare over the next few years.

#25

The Syneos Health Podcast, Coronavirus Special Edition: The Personal Experience | Perspectives

The COVID-19 (coronavirus) outbreak continues to grow worldwide – recently declared by the World Health Organization as a global pandemic – with widespread personal, medical, and business implications.

#26

It's Time for a Digital Reset | Perspectives

What should the evolution of your digital strategy look like through COVID-19 and beyond?

#27

Our Virtual Reality | Perspectives

Virtual collaboration isn’t the future of work – it's the wave of the present

#28

COVID-19: How are Payers Managing These Days? | Perspectives

How are payers responding to COVID-19?

#29

Meet Think Bank | Perspectives

Think Bank is an agile way to answer complex questions.

#30

Pivot Past the Pandemic | Perspectives

Life sciences commercialization in the COVID-19 era and beyond

  • 1
  • 2